李达龙 
在 2023/6/6 19:45:17 进行点评 我要回应
- 审稿时间：15天
- 稿件字数：6500字
- 我的职称：尚无
- 我的学历：硕士
- 是否录用：直接录用
- 查重要求：无查重
- 有无课题：无
- 有无回复：有自动回复
- 投稿难度：较难
- 见刊周期：1个月
- 该刊可发：硕一导二
投稿主题：L临床研究
我的点评：速度快，很快初审就给拒绝了。 感觉有点难审稿。以下是邮件回复
Manuscript ID: TLCR-23-36--
Title: （题目--）
Dear Dr. --,
Your manuscript, noted above, has been reviewed in-house by the Editors of Translational Lung Cancer Research and I regret to report that it has not been accepted for publication.
In order to expedite the review process, the Editorial Office currently uses a two-step procedure: The first involves a screening review by the Editors to determine whether or not the manuscript qualifies for the second step, a peer review. Unfortunately, the initial review of your manuscript indicates that it does not have sufficient priority for acceptance. Thank you for submitting your manuscript to Translational Lung Cancer Research.
We are letting you know about this decision now so that you can promptly submit to another journal.
The significant increase in submissions of manuscripts to the Journal has resulted in intense competition for available space. The Editors have therefore had to raise the bar in defining the criteria for acceptability for publication. As a result, many well conducted studies and interesting reports previously acceptable to the Translational Lung Cancer Research must now, unfortunately, be declined.
We hope our decision to decline your manuscript at this time does not deter you from submitting a paper to us in the future. Thank you for allowing us to consider your manuscript for our journal.
Yours sincerely,
Editorial Office
______________________________
Translational Lung Cancer Research
Email: editor@tlcr.org
URL: https://tlcr.amegroups.com